HomeNews

News

  • FDA Approves First Treatment for Group of Progressive Interstitial Lung Diseases

    • March 23, 2020
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Post-HSCT Cyclophosphamide use Improves Transplantation Outcomes for AML/MDS

    • March 22, 2020
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • FDA approves Opdivo® + Yervoy® for HCC patients previously treated with sorafenib

    • March 22, 2020
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Cadent announces FDA Clearance of IND of CAD-9303 for Schizophrenia

    • March 11, 2020
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • KALYDECO in Cystic Fibrosis receives positive CHMP opinion by EMA

    • October 21, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Positive results from new triple combinations in Cystic Fibrosis, displayed by Vertex

    • October 21, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Dupixent® (Dupilumab) approved by FDA for Asthma indication

    • October 21, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Synspira’s drug receives FDA Orphan Designation for Cystic Fibrosis treatment

    • October 16, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Recent MS survey, sponsored by Celgene, highlights useful patient insights

    • October 16, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Spectramax light therapy can be a potential treatment for Parkinson’s disease

    • October 14, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more